Home Remedies and Ayurvedic Treatment for Diabetes

| November 17, 2018

article image
Prameha, according to Ayurveda is a group of urinary disorders. There are 20 types of urinary disorders (prameha) based on doshas. Among these 20 urinary disorders (prameha rogas), 4 are due to vata, 6 due to pitta and 10 due to kapha. Diabetes that is characterized by an increase in blood sugar levels and frequent micturition is a type of vataja prameha, known as “Madhumeha”. The causative factors and pathogenesis are very important to be noted to decide the best Ayurvedic medicine for diabetes.

Spotlight

CAE Healthcare

CAE Healthcare: Providing solutions for simulation-based medical education (SBME) that improve healthcare, clinical competency, and patient CAE Healthcare delivers advanced, state-of-the-art simulation-based training that enables healthcare professionals to provide safer, high-quality care. Our end-to-end spectrum of solutions include patient, imaging, interventional and surgical simulation, audiovisual solutions, learning applications, and center management programs to drive the future of innovation in training for the benefit of patients and healthcare providers the world over.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

CAE Healthcare

CAE Healthcare: Providing solutions for simulation-based medical education (SBME) that improve healthcare, clinical competency, and patient CAE Healthcare delivers advanced, state-of-the-art simulation-based training that enables healthcare professionals to provide safer, high-quality care. Our end-to-end spectrum of solutions include patient, imaging, interventional and surgical simulation, audiovisual solutions, learning applications, and center management programs to drive the future of innovation in training for the benefit of patients and healthcare providers the world over.

Events